New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

References

• GladkovOMoiseyenkoVBondarenkoINPhase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapyMed Oncol201532662325966791
   PubMed Web of Science ®Google Scholar
• PfeilAMAllcottKPettengellRvon MinckwitzGSchwenkglenksMSzaboZEfficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic reviewSupport Care Cancer201523252554525284721
   PubMed Web of Science ®Google Scholar
• BennettCLDjulbegovicBNorrisLBArmitageJOColony-stimulating factors for febrile neutropenia during cancer therapyN Engl J Med2013368121131113923514290
   PubMed Web of Science ®Google Scholar
• ZseboKMYuschenkoffVNSchifferSVascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSFBlood1988711991033257150
   PubMed Web of Science ®Google Scholar
• KoefflerHPGassonJRanyardJSouzaLShepardMMunkerRRecombinant human TNF alpha stimulates production of granulocyte colony-stimulating factorBlood198770155592439155
   PubMed Web of Science ®Google Scholar
• MetcalfDThe Haematopoietic Colony Stimulating FactorsAmsterdamElsevier19845592
   Google Scholar
• SeelentagWKMermodJJMontesanoRVassalliPAdditive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cellsEMBO J198768226122653499313
   PubMed Web of Science ®Google Scholar
• SouzaLMBooneTCGabriloveJRecombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cellsScience1986232474661652420009
   PubMed Web of Science ®Google Scholar
• DuhrsenUIn vitro growth patterns and autocrine production of hemopoietic colony stimulating factors: analysis of leukemic populations arising in irradiated mice from cells of an injected factor-dependent continuous cell lineLeukemia1988263343423287021
   PubMed Web of Science ®Google Scholar
• DuhrsenUMetcalfDA model system for leukemic transformation of immortalized hemopoietic cells in irradiated recipient miceLeukemia1988263293333287020
   PubMed Web of Science ®Google Scholar
• DuhrsenUVillevalJLBoydJKannourakisGMorstynGMetcalfDEffects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patientsBlood1988726207420813264199
   PubMed Web of Science ®Google Scholar
• EylesJLHickeyMJNormanMUA key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritisBlood2008112135193520118824600
   PubMed Web of Science ®Google Scholar
• MolineuxGKinstlerOBriddellBA new form of filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humansExp Hematol199927121724173410641590
   PubMed Web of Science ®Google Scholar
• RobertsAWMetcalfDGranulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of miceExp Hematol19942212115611637523168
   PubMed Web of Science ®Google Scholar
• WelteKBonillaMAGillioAPRecombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primatesJ Exp Med198716549419483494094
   PubMed Web of Science ®Google Scholar
• CerciCErginCErogluEEffects of granulocyte-colony stimulating factor on peritoneal defense mechanisms and bacterial translocation after administration of systemic chemotherapy in ratsWorld J Gastroenterol200713182596259917552008
   PubMed Web of Science ®Google Scholar
• WeisbartRHKacenaASchuhAGoldeDWGM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanismNature198833261656476482451784
   PubMed Web of Science ®Google Scholar
• GladkovOMoiseyenkoVBondarenkoINA phase iii study of balugrastim versus pegfilgrastim in breast cancer patients receiving chemotherapy with doxorubicin and docetaxelOncologist201621171526668251
   PubMed Web of Science ®Google Scholar
• RattiMTomaselloGLipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropeniaExpert Rev Clin Pharmacol201581152425409861
   PubMed Web of Science ®Google Scholar
• PettengellRJohnsenHELugtenburgPJImpact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphomaSupport Care Cancer201220364765222101611
   PubMed Web of Science ®Google Scholar
• RogersBDongDLiZLiZRecombinant human serum albumin fusion proteins and novel applications in drug delivery and therapyCurr Pharm Des201521141899190725732550
   PubMed Web of Science ®Google Scholar
• HalpernWRiccobeneTAAgostiniHAlbugranin, a recombinant human granulocyte colony stimulating factor (G-CSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeysPharm Res200219111720172912458679
   PubMed Web of Science ®Google Scholar
• AvisarNPukacLAdarLRecombinant albumin-partnering technology: development of balugrastim, a novel long-acting granulocyte colony-stimulating factorBlood2013122214854
   Web of Science ®Google Scholar
• MolineuxGGranulocyte colony-stimulating factorsCancer Treat Res2011157335321052949
   PubMedGoogle Scholar
• HillCPOsslundTDEisenbergDThe structure of granulocyte-colony-stimulating factor and its relationship to other growth factorsProc Natl Acad Sci U S A19939011516751717685117
   PubMed Web of Science ®Google Scholar
• VolovatCGladkovOABondarenkoIMEfficacy and safety of balugrastim compared with pegfilgrastim in patients with breast cancer receiving chemotherapyClin Breast Cancer201414210110824485296
   PubMed Web of Science ®Google Scholar
• MolineuxGFooteMArvedsonTTwenty Years of G-CSF: Clinical and Nonclinical DiscoveriesBaselSpringer Science2012
   Google Scholar
• WiczlingPLowePPigeoletELudickeFBalserSKrzyzanskiWPopulation pharmacokinetic modelling of filgrastim in healthy adults following intravenous and subcutaneous administrationsClin Pharmacokinet2009481281782619902989
   PubMed Web of Science ®Google Scholar
• BuchnerALammerichAAvisarNinventorsTeva Pharmaceutical Industries Ltd, assigneeRecombinant Human Albumin-Human Granulocyte Colony Stimulating Factor for the Prevention of Neutropenia in Pediatric PatientsUnited States Patent US20140271538A12014
   Google Scholar
• MorstynGCampbellLDuhrsenUClinical studies with granulocyte colony stimulating factor (G-CSF) in patients receiving cytotoxic chemotherapyBehring Inst Mitt1988832342392467651
   PubMedGoogle Scholar
• HelmsRAQuanDJTextbook of Therapeutics: Drug and Disease ManagementPhiladelphia, PAWolters Kluwer2006
   Google Scholar
• GabriloveJLJakubowskiAFainKPhase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urotheliumJ Clin Invest1988824145414612459163
   PubMed Web of Science ®Google Scholar
• MorstynGCampbellLSouzaLMEffect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapyLancet1988185876676722895212
   PubMed Web of Science ®Google Scholar
• BronchudMHScarffeJHThatcherNPhase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerBr J Cancer19875668098132829955
   PubMed Web of Science ®Google Scholar
• AvisarNAdarLBockJFirst-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapyCancer Chemother Pharmacol201575592993925740691
   PubMed Web of Science ®Google Scholar
• YangBBKidoAPharmacokinetics and pharmacodynamics of pegfilgrastimClin Pharmacokinet201150529530621456630
   PubMed Web of Science ®Google Scholar
• TigueCCMcKoyJMEvensAMTrifilioSMTallmanMSBennettCLGranulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the research on adverse drug events and reports projectBone Marrow Transplant200740318519217563736
   PubMed Web of Science ®Google Scholar